Oral Semaglutide: First-in-Class Oral GLP-1 Receptor Agonist for the Treatment of Type 2 Diabetes Mellitus
Year: 2019
Type: article
Study design: Systematic Review
Source: Annals of Pharmacotherapy
Author: Kevin Cowart
Institution: University of South Florida
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2989987822
